Anavex Life Sciences Corp (AVXL)

[Gator328]

If that's all that were going to be said, that would probably not have an adverse impact on the share price.

So, I guess the question now becomes what happens if there isn't a PR like that? Can we infer mixed data results? We already know the hit pieces will claim the trial failed no matter what they report (see: NWBO) but I still don't think we will see any similar press releases from the company until CTAD. We'll see...